Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2025-03-31 Purchase | 2025-04-02 7:02 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner | 127,415 | $11.75 | $1,497,322 | 17,382,566 (Indirect) | View |
2025-03-25 Purchase | 2025-03-27 6:53 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner | 97,349 | $12.61 | $1,227,309 | 17,255,151 (Indirect) | View |
2025-03-20 Purchase | 2025-03-24 5:45 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner | 127,198 | $12.92 | $1,643,248 | 17,157,802 (Indirect) | View |
2025-03-17 Purchase | 2025-03-19 6:32 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner | 228,463 | $12.55 | $2,866,553 | 17,030,604 (Indirect) | View |
2025-03-11 Purchase | 2025-03-13 7:35 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner | 1,081,980 | $12.13 | $13,120,914 | 16,802,141 (Indirect) | View |
2024-12-30 Purchase | 2025-01-02 6:17 pm | ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner | 85,098 | $12.92 | $1,099,642 | 7,880,094 (Indirect) | View |
2023-09-19 Purchase(A) | 2023-09-22 3:44 pm | Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP Biotech Opportunity GP LLC Director | 5,313,100 | $1.2596 | $6,692,265 | 12,674,775 (Indirect) | View |
2023-02-19 Purchase | 2023-09-21 8:08 pm | Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP Biotech Opportunity GP LLC Director | 5,313,100 | $1.2596 | $6,692,265 | 19,209,643 (Indirect) | View |
2022-05-05 Purchase | 2022-05-09 06:04 am | ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC NODELMAN OLEG 10% Owner | 668,237 | $21.63 | $14,453,966 | 7,521,024 (Indirect) | View |
2022-05-05 Sale | 2022-05-09 06:04 am | ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC NODELMAN OLEG 10% Owner | 668,237 | $21.63 | $14,453,966 | 7,521,024 (Indirect) | View |
2021-03-31 Purchase | 2021-11-30 6:07 pm | Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP Biotech Opportunity GP LLC Director | 393,168 | $8.8887 | $3,494,733 | 6,534,868 (Indirect) | View |
2021-03-31 Sale | 2021-11-30 6:07 pm | Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP Biotech Opportunity GP LLC Director | 208,142 | $9.9578 | $2,072,642 | 6,534,868 (Indirect) | View |
2021-04-30 Purchase | 2021-05-04 4:51 pm | ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner | 221,500 | $23.24 | $5,147,444 | 7,520,424 (Indirect) | View |
2021-04-23 Purchase | 2021-04-27 6:23 pm | ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner | 147,300 | $23.63 | $3,480,233 | 7,298,924 (Indirect) | View |
2021-04-09 Purchase | 2021-04-13 5:55 pm | Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Panacea Holdings LLC Biotech Opportunity GP LLC Director | 464,500 | $9.8915 | $4,594,594 | 6,721,252 (Indirect) | View |
2021-04-09 Purchase | 2021-04-13 3:10 pm | Panacea Acquisition Corp. II | PANA | EcoR1 Panacea Holdings II LLC NODELMAN OLEG EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Capital LLC Biotech Opportunity GP LLC Director 10% Owner | 545,000 | $10 | $5,450,000 | 545,000 (Direct) | View |
2020-07-06 Purchase | 2020-07-06 5:06 pm | Panacea Acquisition Corp | PANA | EcoR1 Panacea Holdings LLC NODELMAN OLEG EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Capital LLC Biotech Opportunity GP LLC Director 10% Owner | 390,000 | $10 | $3,900,000 | 390,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion